OpenURL Connection Search

Select item for more details and to access through your institution.

Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years.
Published in:
2017
By:
- Martínez, C.;
- Jorge, A.;
- de la Cruz, F.;
- Morales, A.;
- Rodriguez-Salazar, M.;
- Valiente, S.;
- Pérez-Ceballos, E.;
- de Oteyza, J.;
- García-Sanz, R.;
- Pereira, A.;
- Moreno, M.;
- Núñez, J.;
- Gayoso, J.;
- Gonzalez-Medina, J.;
- Revilla, N.;
- Sampol, A.;
- Domingo-Domenech, E.;
- Martínez, C;
- Jorge, A S;
- Núñez, J
Publication type:
journal article
Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation.
Published in:
European Journal of Haematology, 2001, v. 66, n. 2, p. 130, doi. 10.1034/j.1600-0609.2001.00356.x
By:
- Pérez-Ceballos, E.;
- Vallejo, C.;
- Cano, H.;
- Ayala, F.;
- Martinez, F.;
- Moraleda, J.M.;
- Vicente, V.
Publication type:
Article
Novel therapies for the treatment of relapsed‐refractory aggressive B‐cell lymphoma increase survival. Analysis from the RELINF registry of the GELTAMO group.
Published in:
Hematological Oncology, 2023, v. 41, p. 434, doi. 10.1002/hon.3164_320
By:
- Bastos‐Oreiro, M.;
- Abrisqueta, P.;
- Gutierrez, A.;
- Jimenez‐Ubieto, A.;
- Gonzalez de Villambrosia, S.;
- Córdoba, R.;
- López, A.;
- Poza, M.;
- Ceballos, E. Pérez;
- Navarro, B.;
- Muntañola, A.;
- Donato, E.;
- Escoda, L.;
- Luzardo, H.;
- Peñarrubia, M. J.;
- Pardal, E.;
- Belmonte, D. García;
- Lozada, C. Salazar;
- García‐Sancho, A. Martín
Publication type:
Article
AUTOLOGOUS STEM CELL TRANSPLANTATION MAY POTENTIALLY ABROGATE THE NEGATIVE PROGNOSTIC EFFECT OF EARLY RELAPSE AFTER CHEMO OR INMUNOCHEMOTHERAPY IN FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 221, doi. 10.1002/hon.2438_85
By:
- Jiménez Ubieto, A.;
- Grande, C.;
- Caballero, D.;
- Yañez, L.;
- Novelli, S.;
- Hernández ‐ Garcia, M.;
- Manzanares, M.;
- Arranz, R.;
- Ferreiro, J.;
- Bobillo, S.;
- Mercadal, S.;
- Galego, A.;
- López ‐ Jiménez, J.;
- Moraleda, J.;
- Vallejo, C.;
- Albo, C.;
- Pérez ‐ Ceballos, E.;
- Marrero, C.;
- Magnano, L.;
- Palomera, L.
Publication type:
Article

Found: 4

Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years.

Fatal upper and lower gastrointestinal cytomegalovirus disease following autologous peripheral blood stem cell transplantation.

Novel therapies for the treatment of relapsed‐refractory aggressive B‐cell lymphoma increase survival. Analysis from the RELINF registry of the GELTAMO group.

AUTOLOGOUS STEM CELL TRANSPLANTATION MAY POTENTIALLY ABROGATE THE NEGATIVE PROGNOSTIC EFFECT OF EARLY RELAPSE AFTER CHEMO OR INMUNOCHEMOTHERAPY IN FOLLICULAR LYMPHOMA.